Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay

Several programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays have been developed independently within clinical programs for therapeutic anti–programmed cell death protein 1 (anti–PD-1) or PD-L1 antibodies, necessitating assessment of assay comparability. We characterized the Dako PD-L...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thoracic oncology 2020-08, Vol.15 (8), p.1306-1316
Hauptverfasser:	Grote, Hans Juergen, Feng, Zheng, Schlichting, Michael, Helwig, Christoph, Ruisi, Mary, Jin, Hulin, Scheuenpflug, Juergen, Gann, Claudia-Nanette, Su, Zhen, Reck, Martin, Vokes, Everett E., Kerr, Keith M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Avelumab B7-H1 Antigen Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung - drug therapy Humans Immunohistochemistry Lung Neoplasms - drug therapy NSCLC PD-L1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!